Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Clinical Pathology 2004;57:1278-1287; doi:10.1136/jcp.2004.017988
Copyright © 2004 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.
Journal of Clinical Pathology 2004;57:1278-1287
© 2004 BMJ Publishing Group Ltd & Association of Clinical Pathologists

ORIGINAL ARTICLE

Design of a real time quantitative PCR assay to assess global mRNA amplification of small size specimens for microarray hybridisation

V Choesmel, F Foucault, J P Thiery, N Blin

UMR144 CNRS, Research Division, Institut Curie, 75248 Paris cedex 05, France

Correspondence to:
Correspondence to:
Dr N Blin
UMR144 CNRS, Research Division, Institut Curie, 75248 Paris cedex 05, France; Nathalie.Blin{at}curie.fr

Background: Low RNA yields from clinical samples are a limiting step for microarray technology.

Aims: To design an accurate real time quantitative polymerase chain reaction (PCR) assay to assess the crucial step of global mRNA amplification performed before microarray hybridisation, using less than 1 µg total RNA.

Methods: Three RNA extraction procedures were compared for small size samples. Total RNA was amplified from universal RNA or the BC-H1 breast cancer micrometastatic cell line using three different protocols. Real time quantitative PCR technology was used for accurate measurement of urokinase plasminogen activator receptor and cytokeratin 8 RNA amplification rates and ratios, using primer sets binding at various distances from the 3' end of transcripts. A 50 mer oligomeric array targeting 87 genes potentially involved in breast cancer metastatic progression was built and hybridised with amplified RNA.

Results: Eighteen nanograms of total RNA could be purified from 1000 BC-H1 micrometastatic cells. Amplification rates of 25 000 to 100 000 were achieved with as little as 10 ng of starting material. However, results were highly variable, depending on the amount of starting material, gene characteristics, sample quality, and protocols used. Oligomeric array hybridisation with 20 µg reference RNA resulted in specific and reproducible signals for 83% of the genes, whereas mRNA amplification from less than 400 ng of starting material resulted in selective detection of signals from highly expressed genes.

Conclusions: Improvements in the design of global mRNA amplification procedures and oligomeric arrays are needed to extract informative gene expression data from clinical samples containing limited cell numbers.

Abbreviations: aRNA, antisense RNA; BM, bone marrow; Ct, cycle threshold; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; IVT, in vitro transcription; Ker8, cytokeratin 8; PCR, polymerase chain reaction; RT, reverse transcription; rtqPCR, real time quantitative PCR; uPAR, urokinase plasminogen activator receptor; uRNA, universal RNA

Keywords: amplified RNA; in vitro transcription; real time quantitative PCR; oligomeric array; expression profiling


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs